Children's tastes overlooked in clinical trials

While attending the 24th annual DIA Euro Meeting in Copenhagen, Anu Tummavuori, of the CRO Clinigene, said children and their tastes are often overlooked during trials. Original drug formulas may not be best for kids, considering their aversion to certain tastes and inability of some to swallow large capsules, as Natalie Morrison reports in Outsourcing-PharmaArticle

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.